Introduction
============

Genetic crosses and mutagenesis based breeding are time consuming and laborious. The recent development of next generation sequencing is making available fast and cost effective genomic platforms of an increasing number of species including pests, plant models and crops. Now it is easier than ever to perform genome-wide association studies and determine the genes and pathways involved in any particular aspect of pathogen resistance ([@B57]), and pipelines are now well established for genomics-informed breeding ([@B73]). It is also quicker and cheaper to obtain the transcriptome of any crop under pathogen attack and determine the virulence and defense pathways and genes that are deployed by both ([@B40]; [@B56]). Proteomics is also starting to make a dent in understanding plant--pathogen interactions ([@B44]). A complex network of nuclear processes regulating gene expression and function is emerging from this gene discovery phase but association of a particular pathogen effector with the corresponding host target(s) is still poorly understood ([@B51]).

Omics technologies generate a huge amount of data and require powerful computational tools to integrate these high-throughput platforms in order to fully understand the multi-layered networks of biomolecules underpinning plant--pathogen interactions. Gene silencing has been extensively used to validate the function of candidate host resistance genes ([@B24]) and pathogen virulence factors ([@B79]). However, pathogens have evolved effective suppressors against host RNA silencing, making the system unsuitable for engineering strong and durable resistance in crops ([@B61]). A more attractive option is gene targeting (GT) which allows any endogenous gene to be disrupted or replaced with a copy that has been manipulated *in vitro*. In GT experiments, double-stranded break (DSB) at the target gene is repaired by one of the two main competing DNA repair pathways: the more frequent non-homologous end joining (NHEJ) pathway or the rare but precise homologous recombination (HR) ([@B13]). GT could have a huge impact as a 'clean transgenesis' technology for precise gene manipulation or transfer of novel traits into crops. Despite huge efforts, this powerful tool has been elusive in plant science for a long time as it relied on extremely rare spontaneous DSBs ([@B60]). However, this barrier has been recently overcome by the development of novel endonucleases that break DNA specifically at chosen genomic targets. Unfortunately, gene replacement by HR is still inefficient in plants and will need further improvement.

Initially, two endonucleases were engineered by fusing a programmable DNA-binding domain to the cleavage domain of the bacterial restriction enzyme *Fok*I. The first endonuclease was generated by linking the DNA-binding domain of a zinc-finger transcription factor to make the first truly flexible chimeric nuclease zinc-finger nuclease (ZFN) ([@B71]). Similarly, the DNA-binding domain of a transcription activator-like effector of the plant pathogen *Xanthomonas* was used to make the second, and relatively easier to design, nuclease transcription activator-like effector nuclease (TALEN) ([@B16]). These two big breakthroughs were superseded by an even simpler system based on the clustered, regularly interspaced, short palindromic repeats (CRISPR) and CRISPR-associated genes (Cas) used by some bacteria and Archaea to destroy invading genetic material ([@B39]). Our knowledge of CRISPR/Cas is rapidly evolving and the findings are extensively reported and reviewed. Here we will briefly describe the natural and engineered CRISPR--Cas systems followed by the latest and future applications in plant--pathogen interactions.

The Native CRISPR--Cas System
=============================

The CRISPR--Cas system was discovered in bacterial genomes as early as 1987 ([@B37]) but its biological role was determined only in 2007 ([@B4]). These evolving adaptive immune systems against invading phages and plasmids are now re-classified into five types I--V ([@B46]). During the first invasion, the hosts capture short DNA sequences of about 20 nucleotides, known as spacers, from the foreign genetic material and integrate them between two repeats at the CRISPR locus ([@B55]). Upon subsequent encounters, CRISPR arrays with the acquired spacers are transcribed and processed into small CRISPR RNAs containing the spacer (crRNAs). This chimeric molecule interacts with another auxiliary *trans*-activating CRISPR RNA (tracrRNA), forming a duplex RNA or guide RNA (gRNA) that guides the Cas nuclease to the homologous target (protospacer), resulting in an R-loop structure. The tracrRNA activates Cas nuclease activity, cleaving both strands of the target DNA upstream of a conserved protospacer-adjacent motif (PAM). Cas nuclease has two domains, RuvC and HNH, that cut the PAM-containing strand and its complementary strand, respectively, thus producing a single DSB ([@B34]). The spacer and PAM requirements depend on CRISPR--Cas type ([@B78]). In the case of the widely used type II CRISPR--Cas9 system, the last 12 ribonucleotides at the 3′-end of the RNA spacer, known as the seed sequence, dictates the specificity of the complementary target. Mismatches at its 5′-end were thought to be tolerated during gRNA--Cas9 binding to the target. However, the interaction of this region and PAM-distal sequences turned out to be necessary for the activation of Cas9 endonuclease activity ([@B10]). PAM sequences are 2--5 bp motifs essential for spacer acquisition and target cleavage ([@B69]).

Repurposing of the CRISPR--Cas9 System for Gene Editing in Eukaryotes
=====================================================================

The knowledge of the biological function and mechanism of CRISPR--Cas inspired its reprogramming to target any chosen DNA sequence. CRISPR--Cas9 of *Streptococcus pyogenes* was engineered by simply replacing the first 20 nucleotides of crRNA with the intended target sequence and fusing both crRNA and tracrRNA molecules to make a single guide RNA (sgRNA) ([@B39]). This newly programmable system was first adopted to target eukaryotic genes in animals, followed by several successful applications in plants including crops ([@B7]; [@B9]; [@B43]). The ease of implementation of CRISPR--Cas9 by anyone with basic molecular biology skills has made it the tool of choice for gene editing in any species of interest. Upon generating a DSB at the desired site by the Cas9--gRNA complex, the host cell repairs the DNA lesion by NHEJ pathway resulting in short insertions or deletions, leading to gene knockout. The flexibility of the CRISPR--Cas9 system allows targeting of adjacent sites in a single gene for specific removal of a region, which will be extremely useful for the studies of gene and mRNA *cis*-elements and protein domains ([@B8]). CRISPR--Cas9 can also be used in plants to knockout all or single multigene family members ([@B25]) and even multiple unrelated genes ([@B45]).

The DSB lesion can also be repaired by the HR mechanism in the presence of a donor template, leading to precise gene replacement (knock-in). HR-based gene replacement is still inefficient and has been demonstrated in only a few plant species ([@B7]). The efficiency of homology directed repair (HDR) of CRISPR--Cas9 induced DSBs was recently increased by inhibiting the NHEJ pathway in mammalian cells ([@B15]; [@B49]). Cas9 was recently found to dissociate slowly from DSB by releasing first the 3′end of the cleaved DNA strand that is not complementary to the sgRNA. Consequently HDR was increased to 60% in human cells by using rationally designed single-stranded DNA donor template of the optimal length complementary to the strand that is released first ([@B66]). Maize was the first crop where CRISPR--Cas9 was successfully used to generate plants with precise modifications ([@B72]). Precise gene modifications have been achieved at high frequency in tomato by combining the CRISPR--Cas9 nuclease with a geminivirus-based vector for donor DNA template delivery ([@B11]). The combination of some or all of the incremental improvements in different animal and plant species could enhance gene replacement efficiency for all crops.

In pathogens, GT without DSB induction was only improved by inhibiting the NHEJ pathway, as in the ku70 mutant of *Verticillium dahliae* ([@B63]). CRISPR--Cas9 has now made gene editing possible in fungi ([@B50]; [@B54]). The effector Avr4/6 of the soybean pathogen *Phytophthora sojae* was efficiently knocked out or even precisely replaced by the selectable marker *npt*II, uncovering additional roles for the corresponding R gene loci *RPS4* and *RPS6* ([@B27]). The establishment of gene editing tools in *P. sojae* will speed up studies for crop protection in other oomycetes.

Resistance to geminiviruses has been long sought after and was achieved recently in three independent studies using CRISPR--Cas9 in *Nicotiana benthamiana* ([@B1]; [@B3]; [@B38]). In these works, CRISPR--Cas9 was shown to mutate the viral genome, resulting in reduced viral replication and attenuated infection symptoms. A single gRNA targeting a conserved sequence in the replication origin resulted in efficient inhibition of multiple monopartite and bipartite geminiviruses in the same host. However, further studies will be required to monitor the evolution of this resistance over generations and in more challenging environments ([@B12]).

Viral vectors can also be targeted by CRISPR--Cas9 technology to abolish pathogen transmission or even reduce insect population by the so-called mutagenic chain reaction ([@B28]). This system is initiated when both Cas9 and gRNA transgenes are inserted by homology directed repair at the intended target in males. The transgenes are then copied into the homologous chromosome by HR in the germ-line cells. During fertilization, the males transfer the CRISPR--Cas9 cassette into the next generation and the chain continues. This gene drive system has been demonstrated to be very efficient in manipulating two species of mosquito which are vectors for malaria ([@B26]; [@B29]; [@B32]). Though attractive, gene drive will not work in self-fertilizing weeds and non-native invasive plant species but it could potentially be used against flies that are vectors of plant pathogens provided that they are amenable to transgenesis. However, safeguarding against the unintended ecological impact of manipulated insect populations is of great importance and biosafety concerns are starting to be addressed by developing antidote systems to reverse gene drive effects ([@B21]).

Improvements to the CRISPR--Cas9 System Efficiency and Specificity
==================================================================

Since the conception of the CRISPR--Cas9 gene editing system, its components Cas9 and gRNA have been continuously optimized to improve the efficiency and accuracy of GT ([@B6]; [@B31]). The repurposing of the CRISPR--Cas9 system to alter eukaryotic genes necessitated targeting the bacterial Cas9 to the nucleus by adding a nuclear localization signal at one or both termini of the protein. To improve translation efficiency, the Cas9 gene was initially codon optimized for human cells and was quickly followed by several plant versions, for both dicots and monocots ([@B7]). The endonuclease Cas9 can easily be converted into a DNA nickase by a single amino acid change in either of its two domains (D10A in RuvC and H840A in HNH; [@B17]) to cut only one strand. A DSB can still be introduced at the target by these nickases in the presence of two gRNAs that target opposing strands at neighboring sites. This feature has been exploited to improve the specificity of CRISPR--Cas9 and reducing potential off-targets ([@B65]), a major concern with engineered endonucleases in animals ([@B35]) and in plants ([@B7]). Several assays for quantifying on- and off-targets have been developed and inspired strategies for minimizing off-target effects ([@B35]; [@B82]). In plants, the use of whole genome sequencing as the most accurate method is limited to *Arabidopsis* and rice with good genome reference ([@B7]). Unlike in human gene therapy, off-targets are less problematic in plants where one could eliminate such events by backcrosses. The determination of Cas9 structure ([@B53], [@B52]) has also inspired rational engineering of new Cas9 variants with altered PAM recognition ([@B41]) and greater specificity ([@B70]). Orthologs of commonly used Cas9 from *S. pyogenes* (SpCas9) have been reported to have different features and requirements. The *S. aureus* Cas9 (SaCas9) gene is 1 kbp shorter than SpCas9, improving its stability in viral vectors ([@B64]). In the screening effort for SpCas9 orthologs, another protein, Cpf1 (CRISPR from *Prevotella* and *Francisella* 1) of type V CRISPR--Cas systems, has been reported to function in a completely different way to Cas9. Cpf1 does not need a tracrRNA but requires a T-rich PAM motif upstream of the target site and generates a DSB with 5′ overhangs ([@B81]).

The design of guide RNAs for efficient and specific gene editing has also been the focus of many studies combining experimental and computing analyses. Several user-friendly algorithms have been developed and freely shared online with the scientific community^[1](#fn01){ref-type="fn"}^. Most of these bioinformatics tools are designed to score the efficiency of all potential targets with a PAM motif in the input gene sequence ([@B75]). The chance of off-target effects elsewhere in the genome can also be accounted for where the genome sequence is available. These bioinformatics tools are continuously being refined with the availability of new experimental data ([@B47]; [@B76]). The structure of the artificial single guide RNA has been revisited recently and improved by lengthening the duplex crRNA/tracrRNA and improving gRNA transcription by shortening its thymine repeat ([@B18]).

Several systems for delivering Cas9 and gRNA molecules into the cell are available, depending on the species of interest. Plasmid constructs are often used to express Cas9 from RNA polymerase II-driven promoters and gRNAs with polymerase III-mediated transcription. A new strategy based on endogenous tRNA maturation has been developed for expressing multiple gRNAs from a single pol III promoter ([@B45]; [@B77]). While a pol II promoter can be chosen to drive tissue-specific expression of Cas9, snoRNA U3, and U6 pol III promoters are constitutive. However, newly reconstructed sgRNAs can now be expressed from pol II promoters ([@B74]). Inducible promoters can also be used to induce gene editing *in vivo*, yet reduce potential off-target effects and Cas9-associated toxicity ([@B23]). Even better, Cas9 and the gRNA can be simultaneously expressed from a single promoter allowing for more spatio-temporal control of each component ([@B80]). These conditional gene editing methods present new opportunities in crop research but have not yet been tested in plants.

Other Facets of the CRISPR--Cas9 System
=======================================

The CRISPR--Cas9 system has become the tool of choice for gene manipulation owing to its simplicity and the willingness of researchers to share the necessary plasmids and methods, including the various algorithms for designing gRNAs. Most of these ingredients are now deposited with the non-profit plasmid repository Addgene^[2](#fn02){ref-type="fn"}^ ([@B33]). Although most studies focus on knocking out a single gene or a combination of a few targets (multiplexing), the CRISPR--Cas9 system is so powerful that it has been successfully used for genome-wide mutagenesis in mammalian ([@B48]; [@B59]) and *Drosophila* ([@B5]) cells. The CRISPR--Cas9 based genetic screen uses thousands of unique gRNAs covering the genome of interest and relies on efficient delivery of Cas9/gRNA cargo. This type of forward genetic screen will be very useful in studies of plant--pathogen interactions, but the transformation of plant or pathogen cells must be optimized. This goal can be achieved with at least some pathogens and plant models like *Arabidopsis* and tobacco.

When both RuvC and HNH nuclease domains are mutated, Cas9 becomes an inactive or dead endonuclease (dCas9). [@B62] were the first to demonstrate that dCas9 can specifically repress gene expression in *Escherichia coli* in the presence of the gene specific gRNA. This work was quickly followed by another report where dCas9 was fused to transcriptional effectors to silence or activate gene expression in eukaryotes, thereby reversibly manipulating gene expression ([@B30]). Similarly, the epigenome can be manipulated at a specific site by fusing dCas9 with various DNA effectors or histone methylases and acetylases ([@B36]; [@B42]). dCas9-based gene regulation platforms can be used for both genome-wide loss-of-function and gain-of-function screens and the system is amenable to controlled induction ([@B22]). When tagged with fluorescent proteins, dCas9 can be used instead of fluorescence *in situ* hybridization (FISH) to detect chromosomal loci in living ([@B14]) and fixed ([@B20]) cells. In this application, dCas9-fluorescent protein fusions can be targeted by a gRNA to a specific locus in the genome for cytological detection. The simultaneous detection of multiple loci in the same cell is feasible by simply fusing different dCas9 orthologs with different fluorescent proteins. Most of the dCas9-based tools will be very useful in deciphering plant--pathogen interactions. Inducible activation or inhibition of master regulators could have huge practical agronomical applications but the down-side is that the dCas9/gRNA transgenes must be kept permanently in the plant.

Concluding Remarks and Outlook
==============================

Different omics platforms have opened the flood gate of potential disease resistance genes that need a more efficient validation pipeline than earlier gene manipulation tools like gene silencing. Plant--pathogen omics data could be improved even further by reducing the background noise in the biological samples. This can now be achieved, for example, by performing cell-type specific RNA or chromatin profiling with novel tools like INTACT ([@B19]). Cell-type enrichment will help monitor the dynamics of post-translational modifications during plant--pathogen interactions ([@B58]; [@B51]). CRISPR--Cas9 technology has revolutionized gene manipulation capabilities in many species including crops. The multitude of functions that can be performed with CRISPR--Cas9 and its many derivatives ([@B67]) make it a molecular tool that will open new opportunities in the complicated world of plant--pathogen interactions and help design durable crop resistance to pathogens. Only the gene editing function of CRISPR--Cas9 has so far been used in plants and pathogens. However, the future use of dCas9-based tools will also help to unmask the master regulators of disease resistance ([@B68]). GT tools will help integrate omics data in order to fully understand and improve crop defense mechanisms. The complexity of the plant microbiome with good and bad microbes is beginning to be unraveled ([@B2]). CRISPR--Cas9 tools will help future studies of plant--pathogen interactions to transcend individual genes or pathogens and become more holistic in approaches to elucidate plant microbiome systems.
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